Michael Azrin - Concepedia

Author

Michael Azrin

University of Connecticut ORCID

Also Known As

M A Azrin, M. Azrin, MICHAEL A. AZRIN, Michael A Azrin, Michael A. Azrin, Michael Azrin

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

University of Connecticut Hartford Hospital UConn Health Harvard University Brigham and Women's Hospital

About

Michael Azrin is an author at University of Connecticut specializing in medicine, cardiovascular disease, and atherosclerosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	619
2	Biomedical Engineering	2	2	91
3	Public Health	1	1	33
4	Immunology	1	1	25
5	Orthopaedics	1	1	15

Michael Azrin

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
The VIVA Trial Timothy D. Henry, Brian H. Annex, George R. McKendall, Circulation	2003	1K
Rheolytic Thrombectomy With Percutaneous Coronary Intervention for Infarct Size Reduction in Acute Myocardial Infarction Arshad Ali, David A. Cox, Nabil Dib, Journal of the American College of Cardiology Percutaneous Coronary InterventionThrombosisCardiovascular DiseaseCardiologyAcute Myocardial Infarction	2006	284
Effect of lovastatin on intimal hyperplasia after balloon angioplasty: A study in an atherosclerotic hypercholesterolemic rabbit Joel Gellman, Michael D. Ezekowitz, Ian J. Sarembock, Journal of the American College of Cardiology HypertensionVascular DiseaseAtherosclerotic Hypercholesterolemic RabbitCardiovascular DiseaseIntimal Hyperplasia	1991	127
Enhanced Intracoronary Thrombolysis With Urokinase Using a Novel, Local Drug Delivery System Joseph F. Mitchel, Daniel B. Fram, Donald F. Palme, Circulation	1995	78
Antithrombotic Potential of Polymer-Coated Stents Eluting Platelet Glycoprotein IIb/IIIa Receptor Antibody Rajesh Aggarwal, Deborah C. Ireland, Michael Azrin, Circulation	1996	77
Decreased platelet deposition and smooth muscle cell proliferation after intramural heparin delivery with hydrogel-coated balloons. Michael Azrin, Joseph F. Mitchel, Daniel B. Fram, Circulation	1994	69
Localized intramural drug delivery during balloon angioplasty using hydrogel-coated balloons and pressure-augmented diffusion Daniel B. Fram, Thomas Aretz, Michael Azrin, Journal of the American College of Cardiology Pressure-augmented DiffusionMedicineHydrogel-coated BalloonsVascular SurgerySurgery	1994	66
Beneficial effect of glycoprotein IIb/IIIa inhibitor (AZ-1) on endothelium in Escherichia coli endotoxin-induced shock Qian Pu, É. Wiel, Delphine Corseaux, Critical Care Medicine	2001	59
Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention Muthiah Vaduganathan, Robert A. Harrington, Gregg W. Stone, Journal of the American College of Cardiology Percutaneous Coronary InterventionThrombosisCardiovascular DiseasePharmacologyPharmacotherapy	2017	56
Inhibition of platelet deposition and lysis of intracoronary thrombus during balloon angioplasty using urokinase-coated hydrogel balloons. Joseph F. Mitchel, Michael Azrin, Daniel B. Fram, Circulation	1994	51

Page 1